PRAX
Praxis Precision Medicines, Inc.
NASDAQ · Healthcare · Biotechnology · US
$351.81
−0.94%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 60.66x
- P/S forward
- 135.20x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.32x
- Price / sales
- —
- Price / cash flow
- -32.13x
Enterprise value
- Enterprise value
- $9.1B
- EV / sales
- —
- EV / EBITDA
- -26.74x
- EV / EBIT
- -23.97x
- Market cap
- $9.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026